Biocon Limited (BIOCON.NS) Stock Price, News & Chart

	BIOCON.NS	1548.HK	005250.KS	ANTHEM.NS	085660.KQ	3759.HK
Market cap	592.87B	76.81B	438.13B	514.81B	677.77B	55.85B
P/E (TTM)	121.5	—	—	84.4	—	27.4
Forward P/E	33.3	85.8	—	60.4	—	17.2
Price/book	1.7	2.4	—	15.7	—	2.8
Dividend yield	0.15%	—	3.14%	0.23%	—	0.78%
1-year change	−9.86%	+109.10%	−40.79%	+27.52%	−45.74%	+19.72%
Today	+5.10%	−0.94%	+1.47%	+2.84%	+5.96%	+3.47%

Market cap

592.87B

76.81B

438.13B

514.81B

677.77B

55.85B

P/E (TTM)

121.5

—

84.4

—

27.4

Forward P/E

33.3

85.8

—

60.4

—

17.2

Price/book

1.7

2.4

—

15.7

—

2.8

Dividend yield

0.15%

—

3.14%

0.23%

—

0.78%

1-year change

−9.86%

+109.10%

−40.79%

+27.52%

−45.74%

+19.72%

Today

+5.10%

−0.94%

+1.47%

+2.84%

+5.96%

+3.47%

Company	Mkt cap	Price	Today
Genscript Biotech Corporation1548.HK · Biotechnology	76.81B	33.680	−0.94%
GC Corp.005250.KS · Biotechnology	438.13B	9,690.00	+1.47%
Anthem Biosciences LimitedANTHEM.NS · Biotechnology	514.81B	913.55	+2.84%
Chabiotech Co.,Ltd.085660.KQ · Biotechnology	677.77B	7,290.00	+5.96%
Pharmaron Beijing Co., Ltd.3759.HK · Biotechnology	55.85B	30.400	+3.47%
Concord Biotech LimitedCONCORDBIO.NS · Biotechnology	140.75B	672.70	+2.62%
BioNTech SE0A3M.IL · Biotechnology	25.17B	91.50	+2.81%
CTCBIO Inc.060590.KQ · Biotechnology	63.96B	2,675.00	+2.49%

Company	Mkt cap	Price	Today
Pharmicell Co., Ltd.005690.KS · Seoul, South Korea	522.03B	8,700.00	−3.76%
Proteina Co., Ltd.468530.KQ · Seoul, South Korea	578.70B	52,900.00	+23.74%
Chabiotech Co.,Ltd.085660.KQ · Seoul, South Korea	677.77B	7,290.00	+5.96%
Anthem Biosciences LimitedANTHEM.NS · Bengaluru, India	514.81B	913.55	+2.84%
BioNTech SEBNTXN.MX · Mainz, Germany	423.96B	1,710.00	0.00%
GC Corp.005250.KS · Yongin-Si, South Korea	438.13B	9,690.00	+1.47%
Medy-Tox Inc.086900.KQ · Cheongju, South Korea	428.83B	66,400.00	+6.07%
AbClon Inc.174900.KQ · Seoul, South Korea	365.72B	18,330.00	+2.86%

Company	Mkt cap	Price	Today
Santen Pharmaceutical Co., Ltd.4536.T · Drug Manufacturers - General	604.65B	1,882.00	+4.79%
Fortis Healthcare LimitedFORTIS.NS · Medical Care Facilities	618.91B	819.80	+3.69%
Dong-A Pharmaceutical Co.,Ltd.000640.KS · Drug Manufacturers - Specialty & Generic	600.98B	89,300.00	+1.48%
Pharmicell Co., Ltd.005690.KS · Biotechnology	522.03B	8,700.00	−3.76%
WuXi AppTec Co., Ltd.2359.HK · Diagnostics & Research	620.33B	204.400	+3.34%
Aster DM Quality Care LimitedASTERDM.NS · Medical Care Facilities	626.49B	719.55	0.00%
Proteina Co., Ltd.468530.KQ · Biotechnology	578.70B	52,900.00	+23.74%
Abbott India LimitedABBOTINDIA.NS · Drug Manufacturers - Specialty & Generic	571.39B	26,890.00	−0.85%

Company	Mkt cap	Price	Today
Infosys LimitedINFY.NS · Bengaluru, India	4.73T	1,167.40	+3.47%
Titan Company LimitedTITAN.BO · Bengaluru, India	4.29T	4,831.55	+1.72%
Hindustan Aeronautics LimitedHAL.NS · Bengaluru, India	3.37T	5,043.00	−0.71%
Bharat Electronics LimitedBEL.NS · Bengaluru, India	2.89T	395.10	−0.73%
Wipro LimitedWIPRO.NS · Bengaluru, India	1.96T	198.40	+1.98%
Bosch LimitedBOSCHLTD.BO · Bengaluru, India	1.55T	52,450.00	+3.25%
ABB India LimitedABB.NS · Bengaluru, India	1.40T	6,628.00	−1.81%
Hitachi Energy India LimitedPOWERINDIA.BO · Bengaluru, India	1.26T	28,209.00	−2.73%

Company	Mkt cap	Price	Today
Waters CorporationWAT · government · chemicals & materials · life sciences	45.91B	467.60	+1.67%
Syngene International LimitedSYNGENE.BO · chemicals & materials · life sciences · consumers	167.62B	417.05	−0.04%
LanzaTech Global, Inc.LNZA · government · chemicals & materials · life sciences	69.24M	5.29	+4.13%
OraSure Technologies, Inc.OSUR · government · life sciences · industrial	256.56M	3.7200	+5.38%
Gokul Agro Resources LimitedGOKULAGRO.NS · chemicals & materials · life sciences · consumers	65.87B	223.22	+0.07%
Pfizer Inc.PFE.NE · government · life sciences · industrial	237.39B	13.65	+2.55%
Westlake CorporationWLK · government · chemicals & materials · consumers	8.68B	67.90	−0.83%
Jenburkt Pharmaceuticals LimitedJENBURPH.BO · government · life sciences · consumers	4.18B	947.00	+1.83%

Company	Mkt cap	Price	Today
Aurobindo Pharma LimitedAUROPHARMA.NS · Correlation 0.36	1.03T	1,785.00	+4.69%
Divi's Laboratories LimitedDIVISLAB.NS · Correlation 0.34	2.69T	10,140.50	+1.03%
Syngene International LimitedSYNGENE.NS · Correlation 0.33	166.43B	414.10	−0.81%
Canara BankCANBK.NS · Correlation 0.32	1.11T	122.90	+3.87%
Zydus Lifesciences LimitedZYDUSLIFE.BO · Correlation 0.32	1.19T	1,196.40	+0.54%
Glenmark Pharmaceuticals LimitedGLENMARK.NS · Correlation 0.31	700.43B	2,481.80	−0.91%

Company	Mkt cap	Price	Today
LUPIN LIMITEDLUPIN.NS	909.09B	1,988.00	−1.03%
AUROBINDO PHARMA LTDAUROPHARMA.NS	1.03T	1,785.00	+4.69%
GLENMARK PHARMACEUTICALSGLENMARK.NS	700.43B	2,481.80	−0.91%
CIPLA LTDCIPLA.NS	1.13T	1,404.10	+0.15%
DIVI S LABORATORIES LTDDIVISLAB.NS	2.69T	10,140.50	+1.03%

mint·4d agoPositive

Best 3 stocks to buy: SBI, Britannia, Biocon by Ganesh Dongre of Anand Rathi | Targets, stop-loss, stock market views

The Pharma sector emerged as the top performer, rallying nearly 7% during the week. However, despite the recovery in domestic equities, Brent crude oil remains elevated, hovering in the $110–$115 per barrel range, keeping inflationary…

DMA INFY

mint·4d agoNegative

CBI court discharges former joint drugs controller in 2022 Biocon bribery base

A special Central Bureau of Investigation (CBI) court at Rouse Avenue on Saturday discharged Dr. S. Eswara Reddy, former joint drugs controller at the Central Drugs Standard Control Organisation (CDSCO), and three others in a 2022 bribery…

EquityBulls·Oct 25Positive

Biocon Secures Market Entry for Yesintek™, a Proposed Biosimilar to Stelara®, in Additional Global Markets

26 Oct 2026, 08:52 AM IST Equity Bulls Stock Report Biocon Limited INE376G01013 This milestone builds on the Company’s previously announced agreements with Janssen that secured market entry dates for Yesintek™ in the United States, and in…

LLY SNY NVO

TaxGuru·Oct 29Positive

Biocon recognised as top employer in global biotech and pharma for 2026

Read the Biocon Limited announcement filed with the NSE, with the key figures and what it means for shareholders. Biocon Limited, a prominent biopharmaceutical company headquartered in Bengaluru, India, has been ranked 13th among the top…

LLY NVS SNY PFE

Express Pharma·Oct 26Positive

Biocon secures Yesintek biosimilar rights in nine markets

Biocon has signed a licence agreement with Janssen Sciences Ireland to enable the commercialisation of Yesintek, its proposed biosimilar to Stelara (ustekinumab), in Australia, Brazil, China, Hong Kong, Israel, Mexico, New Zealand, South…

NewsX·Oct 7

Electrical Products Maker Biocon Electric Limited Files DRHP with SEBI for IPO of up to 59,00,000 Equity Shares; Proposes Listing on the Main Board of BSE Limited and National Stock Exchange of India Limited

Bengaluru (Karnataka) [India], October 7: Biocon Electric Limited (“the Company”), a multi-category electrical products company selling under the “BIOCON” brand, has filed its Draft Red Herring Prospectus (DRHP) with SEBI for an initial…

Univest·Oct 21Negative

Biocon Share Price Hits Fresh 52-Week Low, Valuation View

Biocon Ltd. (BIOCON) traded at Rs 337.45 versus the previous close of Rs 340.5, a fall of 0.9%. The stock opened at Rs 341, reached a high of Rs 343.85, touched a low of Rs 336.6. In market terms, Biocon Share Price News is being read…

BIIB

BusinessLine·Oct 14Positive

Biocon gets launch clarity for breast cancer biosimilar after Genentech deal

Biocon has secured a clearer timeline for commercialising its pertuzumab biosimilar, Pebrilzo, after reaching a global patent settlement and licensing agreement with Genentech, resolving disputes that had clouded its market entry plans.…

EMA AZN PFE

TradingView·Oct 15·4 outletsPositive

Biocon Secures Licensed Launch Dates For Pebrilzo Following Genentech Patent Settlement

Global agreement clears pending patent disputes and allows Biocon to launch its pertuzumab biosimilar across key markets from 2026-28 Biocon Limited has entered into a global patent settlement and licence agreement with Genentech, securing…

EMA

Biocon settles patent dispute with Genentech over breast cancer drug Pebrilzo; US launch in 2028

Biocon Ltd on Wednesday said it has entered into a global settlement and license agreement with Genentech for breast cancer drug Pebrilzo, its biosimilar to the reference product Perjeta (Pertuzumab). The patent settlement agreement…

EMA AZN BMY

Install

Biocon Limited

Key statistics

Against its peers

Latest news